Este Medical Group Expands Advanced Hair Transplant Services in Edinburgh Amid Rising Local Demand
To view an enhanced version of this graphic, please visit:
Located in the heart of the city at 37 York Place, the clinic is now offering enhanced treatment options including FUE (Follicular Unit Extraction) and DHI (Direct Hair Implantation) - two of the most effective techniques available for achieving natural-looking, permanent results.
'We've seen a sharp increase in patients travelling from across Scotland for expert treatment,' said Bobby Kang, Director Este medical Group Edinburgh. 'Our goal is to make world-class hair loss clinic Edinburgh services more accessible, with a focus on minimally invasive procedures and rapid recovery.'
Este Medical's Edinburgh team of specialists tailor every treatment to the individual, aiming for high graft survival rates and visibly fuller results. With hair loss affecting more than 50% of men and a growing number of women in the UK, the need for expert-led, clinically proven care has never been higher.
In addition to transplants, the clinic is expanding its offerings for clients seeking non-surgical options - including the latest in Alopecia Treatment Edinburgh. These therapies cater to a wide range of hair loss conditions such as androgenetic alopecia, alopecia areata, and postpartum shedding.
'Patients trust us because we combine cutting-edge technology with compassionate care,' added Bobby Kang. 'By expanding our services in Edinburgh, we're empowering more people to feel confident again.'
Media Contact:
Sumit Singh
37 York Place, Edinburgh EH1 3HP, Scotland
Phone: 0131 605 0323
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Micromem Technologies Launches Ultra-Sensitive Liquid-Phase Sensor Targeting Disease Biomarkers with Breakthrough Picomolar Detection
Toronto, Ontario and New York, New York--(Newsfile Corp. - August 11, 2025) - Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) ("Micromem" or the "Company") is pleased to announce the successful development of its liquid-phase nanowire bio-chemical sensor, engineered to detect disease-associated biomarkers at ultra-low concentrations. This innovation marks a critical milestone in the pursuit of more accurate, earlier medical diagnostics. The sensor has demonstrated limit-of-detection performance down to 1 picomolar (pM) and 20mV/decade sensitivity, enabling the identification of inflammatory and pathological biomarkers previously undetectable by conventional methods. The sensor platform is fabricated using standard photolithography processes, making it both cost-effective and scalable for high-volume industrial applications. The initial target analyte is TREM-1 (Triggering Receptor Expressed on Myeloid Cells 1), a key marker known to amplify inflammatory responses and closely associated with a range of diseases including atherosclerosis, cancer, colitis, and fibrosis. Platform Highlights: Ultra-Low Detection Thresholds: Achieves pM-level detection, suitable for early-stage disease monitoring. Broad Diagnostic Utility: Customizable for other critical biomarkers involved in cancer, autoimmune disease, and systemic inflammation. High Signal Clarity: Nanowire-based response delivers real-time, low-noise output with a strong correlation to analyte concentration. Compact and Integratable: Ready for deployment in next-generation lab-on-a-chip, point-of-care, or remote diagnostic devices. Manufactured via conventional photolithography techniques, the platform supports efficient, low-cost production-critical for widespread adoption in clinical and point-of-care diagnostics. Market Relevance With global demand for biomarker diagnostics expected to exceed $100 billion USD by 2030¹, Micromem's platform presents a compelling opportunity for partnerships with biotech, pharmaceutical, and diagnostics companies seeking next-generation sensor technologies. This liquid-phase sensor platform originated from work developed on behalf of the Department of National Defence and is evolving into a commercial diagnostic tool. Micromem is positioning its gas detection technology for integration into industrial and environmental systems through targeted partnerships and pilot initiatives. Precision medicine starts with precision detection. The Company's platform offers the sensitivity, flexibility, and scalability to support a wide array of clinical applications. With the platform now ready for field validation, the Company is seeking co-development and deployment opportunities with strategic industry partners. Micromem is focused on expanding commercial readiness and welcomes pilot deployment opportunities. About Micromem Micromem Technologies Inc. and its subsidiaries, a publicly traded company (CSE: MRM) (OTCQB: MMTIF),develops, and commercializes advanced sensor solutions using proprietary nanotechnology and analyzes specific industry sectors to create intelligent game-changing applications that address unmet market needs. It creates platforms the serve the needs of industries that demand accuracy, durability, and real-time intelligence in detection systems. By leveraging its expertise and experience with sophisticated sensor applications, the Company successfully powers the development and implementation of innovative solutions for oil & gas, utilities, automotive, healthcare, government, information technology, manufacturing and other industries. Visit Safe Harbor Statement This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; continued consumer adoption of digital technology; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer and technological demands; inability to replace significant customers; seasonal nature of our business; and other risks detailed in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements. The CSE or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management. ### Listing: OTCQB - Symbol: MMTIFCSE - Symbol: MRMShares issued: 607,024,014SEC File No: 0-26005 Investor Contact: info@ Tel. 416-364-2023 Subscribe to receive News Releases by Email on our website's home page. ¹ According to Grand View Research, the global biomarkers market was valued at USD 59.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 13.2% from 2023 to 2030, reaching over USD 110 billion by 2030. To view the source version of this press release, please visit Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Associated Press
03-08-2025
- Associated Press
Dr. Louis Krenn Launches Nationwide Medical Scholarship to Support Aspiring Healthcare Professionals Across the U.S.
Springfield, Missouri--(Newsfile Corp. - August 3, 2025) - The Dr. Louis Krenn Medical Scholarship, founded by seasoned Family Medicine physician Dr. Louis Krenn, is now officially open for applications from undergraduate and medical students pursuing careers in medicine across the United States. The scholarship aims to recognize and support emerging medical leaders who are committed to service, innovation, and compassion in healthcare-values that define Dr. Louis Krenn's own professional journey. [ This image cannot be displayed. Please visit the source: ] Dr. Louis Krenn Launches Nationwide Medical Scholarship to Support Aspiring Healthcare Professionals Across the U.S. To view an enhanced version of this graphic, please visit: Open to current undergraduate or medical students enrolled in accredited U.S. institutions, the scholarship invites applicants to submit an original essay addressing the prompt: 'Medicine is more than a career-it's a calling. What inspired you to pursue a path in healthcare, and how do you hope to shape the future of medicine through your work?' Essays will be evaluated based on originality, depth of reflection, and alignment with the core principles upheld by Dr. Louis Krenn throughout his career in clinical practice and healthcare leadership. The Dr. Louis Krenn Medical Scholarship reflects a long-standing commitment to education and mentorship. Throughout his more than 20 years in medicine, Dr. Louis Krenn has served in numerous leadership roles, including Medical Director of Ambulatory Clinical Efficiency, Chief Medical Information Officer, and Director of Telehealth, while also actively mentoring medical, nursing, and physician assistant students. His multifaceted career demonstrates a consistent dedication to improving clinical systems, expanding access to care through telehealth, and preparing future physicians for the challenges of modern medicine. Applicants must be enrolled in a pre-med or medical track and submit a thoughtful essay of 500 to 800 words. The deadline to apply is March 15, 2026, and the winner will be announced on April 15, 2026. This scholarship is not limited by geography and is available to students across all U.S. states, encouraging a broad and inclusive pool of future medical professionals to reflect on their aspirations and personal motivations for entering the healthcare field. The scholarship is guided by Dr. Louis Krenn's belief that medical students are not only training to treat patients but also shaping the future of healthcare systems, access, and innovation. This initiative is a tangible continuation of his mission to support meaningful progress in medicine-through those who will carry the torch forward. The Dr. Louis Krenn Medical Scholarship will be awarded to one student whose essay best captures the spirit of dedication to patient care and forward-thinking healthcare solutions. By focusing on both the personal calling and the broader impact of future physicians, the scholarship honors the legacy and leadership of Dr. Louis Krenn, while also investing in the promise of tomorrow's medical professionals. Contact Information: Spokesperson: Dr. Louis Krenn Organization: Dr. Louis Krenn Medical Scholarship Website: Email: [email protected] To view the source version of this press release, please visit
Associated Press
03-08-2025
- Associated Press
Dr. Hazem Afifi Launches Nationwide Scholarship to Support Aspiring Medical and Nursing Students Across the U.S.
Las Vegas, Nevada--(Newsfile Corp. - August 3, 2025) - The Dr. Hazem Afifi Scholarship for Medical Students is now officially open for applications, inviting undergraduate students across the United States who are pursuing careers in medicine, nursing, or related healthcare disciplines to apply for a one-time award. Spearheaded by Dr. Hazem Afifi, a distinguished and board-certified medical professional based in Las Vegas, this scholarship initiative reflects his unwavering commitment to education, academic excellence, and the future of healthcare. [ This image cannot be displayed. Please visit the source: ] Dr. Hazem Afifi Launches Nationwide Scholarship to Support Aspiring Medical and Nursing Students Across the U.S. With an application deadline of February 15, 2026, the Dr. Hazem Afifi Scholarship for Medical Students is open to all eligible undergraduate students currently enrolled at accredited U.S. colleges or universities. The scholarship recognizes individuals who demonstrate strong academic performance, a genuine commitment to the medical profession, and a passion for patient-centered care. Applicants are required to submit an original 500-700 word essay addressing the prompt: 'What inspired you to pursue a career in medicine or nursing, and how do you plan to make a meaningful impact in the lives of your future patients?' Submissions will be reviewed based on clarity, originality, personal insight, and alignment with the core values of the scholarship program. The recipient of the scholarship will be officially announced on March 15, 2026. Dr. Hazem Afifi has built a career defined by clinical excellence, academic involvement, and a sincere interest in mentoring future leaders in healthcare. Throughout his medical journey, he has engaged with students from diverse backgrounds, encouraging them to embrace their passion for healing and service. With the introduction of this scholarship, Dr. Hazem Afifi aims to support students not only financially but also by recognizing their potential and validating their dedication to improving patient outcomes. This scholarship is not limited by geographic region, allowing students from all states and cities across the United States to apply, thereby reinforcing Dr. Hazem Afifi's belief in equitable access to opportunity and education. By removing regional limitations, the initiative ensures that qualified individuals from all communities can benefit from this academic support. The Dr. Hazem Afifi Scholarship for Medical Students represents more than just a financial contribution; it stands as a symbol of encouragement and acknowledgment for future healthcare professionals at a formative stage of their educational path. The scholarship is a reflection of Dr. Hazem Afifi's lifelong mission to foster a healthier future through education, mentorship, and support for the next generation of practitioners. To learn more about the scholarship criteria and to access the application portal, students are encouraged to visit the official website: Contact Information: Spokesperson: Dr. Hazem Afifi Organization: Dr. Hazem Afifi Scholarship for Medical Students Website: Email: [email protected] To view the source version of this press release, please visit
